Technical Advisory Board

A world-renowned neuromuscular disease researcher and professor at Texas A&M University, Dr. Nghiem brings decades of translational expertise using large-animal models to advance therapies for muscular dystrophy and related conditions.

​

​

A seasoned biotech strategist and translational science expert, Dr. Gosh brings deep experience in bridging early-stage discoveries with commercial development. Her cross-disciplinary background helps Bioramics evaluate scientific viability, market readiness, and partnership alignment for breakthrough preclinical assets.

A leading authority in materials science and former university research executive, Dr. Brow offers decades of expertise in scientific innovation, academic-industry collaboration, and technology commercialization. His guidance supports Bioramics in evaluating technical feasibility and scaling strategies for advanced biomedical applications.

An internationally respected leader in muscle biology, Dr. Selsby specializes in preclinical research focused on muscle regeneration, injury recovery, and degenerative disease. His deep scientific expertise enhances Bioramics’ ability to assess therapeutic potential and accelerate translational success across its portfolio.

A clinical development specialist with broad experience in biotech and translational medicine, Dr. Zingariello provides strategic guidance on trial readiness, regulatory alignment, and therapeutic positioning. Her clinical insight ensures that Bioramics’ preclinical assets are advanced with real-world application and patient impact in mind.

A rising expert in translational medicine and preclinical research, Dr. Gomes brings valuable insight into tissue repair, regenerative biology, and therapeutic evaluation. Her scientific contributions help Bioramics ensure that emerging technologies are rigorously validated and positioned for downstream development.

​

A seasoned executive with deep experience in corporate growth, strategic operations, and commercialization pathways, Herm Hasken advises Bioramics on how to maximize the market value of its preclinical assets. His practical business insight and leadership in scaling emerging ventures help bridge the gap between innovation and acquisition.

​

A devoted advocate and parent of a child living with muscular dystrophy, Kristen Cox brings a vital patient-family perspective to the Bioramics Board of Technical Advisors. Based in College Station, Texas, she offers firsthand insight into the urgent needs of affected families and helps ensure that Bioramics’ work remains grounded in compassion, impact, and real-world relevance.

A young man living with muscular dystrophy in College Station, Texas, Kyle Cox serves as an inspiration and reminder of the urgent mission behind Bioramics’ work. His lived experience brings authenticity and clarity to the patient voice, helping guide development priorities that matter most to those directly impacted by rare neuromuscular diseases.

​